首页> 外文期刊>Cornea >Herpetic epithelial keratitis after intravitreal injection of bevacizumab.
【24h】

Herpetic epithelial keratitis after intravitreal injection of bevacizumab.

机译:玻璃体内注射贝伐单抗后疱疹性上皮角膜炎。

获取原文
获取原文并翻译 | 示例
       

摘要

We read with great interest the case report entitled "Herpetic epithelial ker-atitis after intravitreal injection of bev-acizumab (avastin)" by Khalili et al.1 The authors reported a case of herpetic epithelial keratitis 3 days after intravitreal injection of bevacizumab.In their article, the authors did not state which dose of bevacizumab was injected intravitreally. It is not clear that the authors used a standard dose (1.25 mg/0.05 mL) or an overdose of bevacizumab. We agree with the authors that there are a lot of unknown things about bevacizumab. We think that the authors should also consider possibility of coincidental occurrence of herpetic epithelial keratitis with intravitreal bevacizumab injection in this patient.
机译:我们非常感兴趣地阅读了Khalili等人的题为“玻璃体内注射bev-acizumab(avastin)后的肝性上皮角膜炎”的病例报告。1作者报告了玻璃体内注射贝伐单抗3天后疱疹性上皮角膜炎的病例。在他们的文章中,作者没有说明玻璃体内注射哪种剂量的贝伐单抗。尚不清楚作者是否使用标准剂量(1.25 mg / 0.05 mL)或过量的贝伐单抗。我们同意作者的观点,关于贝伐单抗有很多未知的事情。我们认为作者还应考虑在该患者中玻璃体腔注射贝伐单抗同时发生疱疹性上皮性角膜炎的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号